Company / Operating Margin
Actinium Pharmaceuticals, Inc. Operating Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-40274.4%
FY2025
5-year range
-64098.8% / -1957.4%
FY2021-FY2025
Trend
+37.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin returned to growth in FY2025 after 3 years of decline, reaching -40274.4%.
Based on SEC 10-K filings.
-40274.4% in FY2025 with a 3-year CAGR of -38092.3%.
Declined from -3311.1% to -40274.4% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -38092.3pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 37.2% year-over-year.
- Peak operating margin was recorded in FY2021.
- Lowest operating margin in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -40274.4% | +37.2% |
| FY2024 | -64098.8% | -1835.9% |
| FY2023 | -3311.1% | -51.7% |
| FY2022 | -2182.2% | -11.5% |
| FY2021 | -1957.4% | - |
| FY2011 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026